Posted in | News | Lead | Silver | Zinc | Discoveries

ECU Silver Mining Discovers Mantos-Type Mineralized Zone at Chicago Mine

ECU Silver Mining Inc. (TSX:ECU) has announced that it has discovered a "mantos-type" mineralized zone in the new underground development at the Chicago mine.

The newly discovered zone included a cut assaying 350 grams per tonne (g/t) silver (Ag), 6.40% lead (Pb) and 12.13% Zn over a width of 3.0 meters (m) (10 feet).

Michel Roy, CEO and Chairman of ECU stated, "The mantos-type of mineralization is typically related to replacement bodies which is a very encouraging development for us, as some of the best orebodies in Mexico are of this type of mineralization. Historical mining in "mantos" style deposits have shown that these types of mineralization are generally associated with very high grades and good widths."

The new mineralization was discovered through an underground drift that was following the "Gambusinos" vein in the Chicago mine. The mantos is differentiated from the mineralized veins in that the mineralization consists of replacement bodies inserted between limestone beds. This type of mineralization, while normally limited in lateral extent, can be followed for significant distances along its plunge and is typically much wider than normal veins. The mantos deposits typically contains higher than normal grades of silver, lead and zinc. Assays to date are:

To date, six cuts have been assayed with an average grade of 161 g/t Ag, 2.45% Pb and 4.70% Zn over an average width of 3.3 m (11 feet). Much higher grades can commonly exist in mantos style deposits which would suggest that the newly discovered zone is near the top of the structure. Consequently it is expected that grades will improve as development goes further down plunge along the mantos.

Source:

ECU Silver Mining Inc.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.